Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Magnetic Resonance Spectroscopy 27 Specimen Handling 26 enzalutamide 23 Prednisone 22 Abiraterone Acetate 19 apalutamide 17 Androgen Antagonists 17 darolutamide 13 Leuprolide 12 Radiotherapy 10 Pluvicto 10 Radiosurgery 9 Biopsy 9 cabazitaxel 8 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 abiraterone 8 X-Rays 8 Goserelin 8 bicalutamide 7 Photons 7 Docetaxel 7 relugolix 6 prednylidene 6 luprolide acetate gel depot 6 gallium 68 PSMA-11 6 deltacortene 6 Triptorelin Pamoate 6 Gonadotropin-Releasing Hormone 6 Glutamate Carboxypeptidase II 6 Brachytherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡